Clinical Trial

MANDARIN (S6371)

Name: MANDARIN (S6371) — clinical trial record (NCT05016245)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of TheraSphereTM yttrium \[90Y\] glass microsphere in the Chinese patients with inoperable hepatocellular carcinoma.

Protocol Amendment History 2 changes

critical Trial completed 2026-08-13

minor Completion moved earlier: 2026-10-30 -> 2026-08-10 2026-08-13

Trial Details

NCT Number	NCT05016245
Lead Sponsor	Boston Scientific Corporation
Conditions	Inoperable Hepatocellular Carcinoma
Enrollment	92 participants
Start Date	2021-09-13
Primary Completion	2026-02-13 (estimated)
Study Completion	2026-08-10 (estimated)
Updated on ClinicalTrials.gov	2026-08-12